Randomized Controlled Clinical Outcomes of the Vanguard XP Bicruciate Knee System

NATerminatedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
OsteoarthritisRheumatoid ArthritisTraumatic ArthritisLower Limb DeformityPost-traumatic DeformityComplications, Arthroplasty
Interventions
DEVICE

Vanguard XP Bicruciate Knee System

The Vanguard XP is a bicruciate retaining total knee design and is constrained by natural soft tissue.

DEVICE

Vanguard CR Knee System

The Vanguard CR system requires the ACL to be sacrificed and is constrained by soft tissue and device design.

Trial Locations (2)

60605

Midwest Orthopaedics at Rush University Medical Center, Chicago

84108

University of Utah Orthopaedic Center, Salt Lake City

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Zimmer Biomet

INDUSTRY

NCT02175576 - Randomized Controlled Clinical Outcomes of the Vanguard XP Bicruciate Knee System | Biotech Hunter | Biotech Hunter